| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.156 | 78.254 | 97.198 | 101.793 | 52.041 | 44.585 | 79.156 | 85.634 | 95.319 |
| Total Income - EUR | - | 19.156 | 78.254 | 97.198 | 101.793 | 52.041 | 44.585 | 79.156 | 85.954 | 98.176 |
| Total Expenses - EUR | - | 11.582 | 47.537 | 47.631 | 52.637 | 34.719 | 31.452 | 48.684 | 50.694 | 50.507 |
| Gross Profit/Loss - EUR | - | 7.574 | 30.717 | 49.567 | 49.157 | 17.322 | 13.134 | 30.472 | 35.260 | 47.668 |
| Net Profit/Loss - EUR | - | 6.997 | 29.931 | 48.595 | 48.126 | 16.807 | 12.682 | 29.683 | 34.414 | 45.916 |
| Employees | - | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Siboptic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 249 | 458 | 2.910 | 1.242 | 2.470 | 2.599 | 1.843 | 2.614 | 2.853 |
| Current Assets | - | 9.576 | 32.726 | 51.612 | 82.210 | 29.499 | 24.965 | 34.882 | 50.480 | 97.018 |
| Inventories | - | 5.060 | 2.617 | 6.894 | 7.537 | 6.908 | 5.970 | 6.452 | 2.204 | 4.020 |
| Receivables | - | 0 | 0 | 18 | 65 | 472 | 32 | 17.582 | 1.756 | 1.455 |
| Cash | - | 4.516 | 30.109 | 44.700 | 74.608 | 22.120 | 18.963 | 10.848 | 46.520 | 91.544 |
| Shareholders Funds | - | 7.042 | 30.287 | 48.670 | 78.153 | 29.188 | 22.786 | 29.890 | 47.029 | 92.682 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.783 | 2.898 | 5.853 | 5.299 | 2.781 | 4.778 | 6.835 | 6.064 | 7.189 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Siboptic Srl